An RNA-based precision oncology platform for patient-therapy alignment in a diverse set of treatment resistant malignancies [meningioma sample]
GSE212854Mundi et al., 2023
Overview
- Modality
- Bulk RNA-seq
- Sample count
- 1
- Patient count
- 1
- Institution
- Columbia University
- Corresponding author
- Mariano J Alvarez, Andrew L Kung, Andrea Califano
- Platform
- RNA-seq (Illumina), exact chemistry not specified per-sample
- Access type
- open
- Tissue preservation
- Not reported
- WHO edition
- Not reported
Cohort detail
- Grade breakdown
- G1: 0 G2: 1 G3: 0
- Sex distribution
- Not reported
- Age distribution
- Not reported
- Anatomic location
- Meninges (recurrence site stated explicitly in the sample title)
- Brain invasion
- Not reported
- Normal/control tissue
- None
Priority attributes
Peer-reviewed
Publications
- Mundi PS, et al. A Transcriptome-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies. Cancer Discovery, 2023. PMID 37061969 · DOI
Sources
- GEOhttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE212854
- GEOhttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM6559659
- PubMedhttps://pubmed.ncbi.nlm.nih.gov/37061969/
- PMC full texthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239356/